Benitec Biopharma Inc.

Nasdaq:BNTC

Pharmaceutical Preparations·HAYWARD, CA

Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference (ddRNAi) technology.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/12/26	→
10-Q	Q3 2025	9/30/25	11/14/25	→
10-K	FY 2025	6/30/25	9/22/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-Q	Q4 2024	12/31/24	2/14/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
2/12/26	Q3 FY2026	→
11/14/25	Q2 FY2026	→
9/22/25	Q1 FY2026	→
5/14/25	Q4 FY2025	→
2/14/25	Q3 FY2025	→
11/14/24	Q2 FY2025	→
↓

News (8-K)

55 shown

Filed	Type	Description
12/2/25	Vote	Submission of Matters to a Vote of Security Holders	→
11/7/25	Agreement	Entry into a Material Definitive Agreement	→
11/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/12/25	Restatement	Non-Reliance on Previously Issued Financial Statements	→
7/9/25	Reg FD	Regulation FD Disclosure	→
3/28/25	Other	Other Events	→
↓

Prospectuses & Registrations

38 shown

Filed	Form	Description
2/11/26	424B3	424B3	→
1/30/26	S-3	S-3	→
11/7/25	424B5	424B5	→
11/5/25	424B5	424B5	→
9/22/25	S-3	S-3	→
6/2/25	424B3	424B3	→
↓

Filing History(312 filings)

TypeDateAccessionPeriodSize

8-K

Feb 12, 2026

0001193125-26-0477428-K

Feb 12, 2026

779.4 KB

10-Q

Feb 12, 2026

0001193125-26-04773710-Q

Dec 31, 2025

7.2 MB

424B3

Feb 11, 2026

0001193125-26-044984424B3

—

162.7 KB

EFFECT

Feb 10, 2026

9999999995-26-000516

—

1.7 KB

S-3

Jan 30, 2026

0001193125-26-031753S-3

—

356.5 KB

SCHEDULE 13G/A

Jan 29, 2026

0000038777-26-000024

—

21.2 KB

Jan 26, 2026

0001012975-26-000082STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Jan 22, 2026

5.0 KB

Dec 29, 2025

0000899140-25-001479

Dec 23, 2025

36.7 KB

Dec 22, 2025

0000899140-25-001459

Dec 18, 2025

37.7 KB

SCHEDULE 13G/A

Dec 8, 2025

0001274173-25-000332

—

10.8 KB

SCHEDULE 13G

Dec 3, 2025

0001346824-25-000066

—

18.2 KB

Dec 3, 2025

0001012975-25-000851STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 1, 2025

5.0 KB

Dec 3, 2025

0001012975-25-000850STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 1, 2025

5.7 KB

Dec 3, 2025

0001012975-25-000849STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 1, 2025

5.0 KB

Dec 3, 2025

0001012975-25-000848STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 1, 2025

5.0 KB

Dec 3, 2025

0001012975-25-000847STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Dec 1, 2025

4.9 KB

8-K

Dec 2, 2025

0001193125-25-3054758-K

Dec 1, 2025

164.7 KB

Nov 20, 2025

0001012975-25-000813STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Nov 18, 2025

5.0 KB

Nov 20, 2025

0001012975-25-000812STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Nov 18, 2025

5.0 KB

Nov 20, 2025

0001012975-25-000811STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Nov 18, 2025

5.0 KB

8-K

Nov 14, 2025

0001193125-25-2833518-K

Nov 14, 2025

213.6 KB

10-Q

Nov 14, 2025

0001193125-25-28327410-Q

Sep 30, 2025

6.6 MB

DEFA14A

Nov 12, 2025

0001193125-25-275653DEFA14A

—

15.0 KB

SCHEDULE 13D/A

Nov 10, 2025

0000899140-25-001257

—

102.5 KB

Nov 10, 2025

0000899140-25-001256

Nov 7, 2025

27.0 KB

25 filings shown

Benitec Biopharma Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(312 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/12/25	DEFA14A	DEFA14A	→
10/14/25	DEFA14A	DEFA14A	→
10/14/25	DEF 14A	DEF 14A	→
11/14/24	DEFA14A	DEFA14A	→
10/22/24	DEF 14A	DEF 14A	→
10/22/24	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
1/26/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
12/29/25	4	4	→
12/22/25	4	4	→
12/3/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
12/3/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
12/3/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
↓

Filed	Form	Description
2/10/26	EFFECT	EFFECT	→
1/29/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/8/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/3/25	SCHEDULE 13G	SCHEDULE 13G	→
11/10/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
11/4/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓